Pioneering Genomics Research for a Healthier Future
Imagine receiving a life-saving organ transplant — and never needing to take a single anti-rejection pill for the rest of your life. That future is closer than you think, and Axiom BioLabs is leading the way.
We hold the only patent for CAR-T cell therapy in the field of organ transplantation — a distinction that places us at the frontier of one of medicine's most profound challenges. Today, every organ transplant recipient must take immunosuppressive drugs daily, often for a lifetime. These medications carry serious side effects: heightened vulnerability to infections, increased cancer risk, kidney damage, and diminished quality of life. Our patented approach engineers a patient's own T-cells to teach the immune system to accept a transplanted organ as "self" rather than attacking it as foreign. The result? The potential to achieve true immune tolerance — where the body peacefully coexists with its new organ without the need for lifelong medication.
This is not just an incremental improvement. It is a paradigm shift that could redefine transplant medicine for the more than 130,000 people worldwide who receive organ transplants each year.
Beyond transplantation, our Cell Therapy Division develops advanced CAR-T therapies for blood cancers like non-Hodgkin's lymphoma and leukemia, and is pursuing early-phase clinical trials for autoimmune conditions such as lupus and rheumatoid arthritis. Our Diagnostics & Testing Division delivers precise molecular services — from genetic testing and CRISPR gene editing to environmental analysis of water, soil, and air quality.
Please reach us at Dr.JohnWhite@axiombiolabs.org if you cannot find an answer to your question.
Our research spans three transformative frontiers. In oncology, we develop CAR-T cell therapies that reprogram a patient's own immune cells to hunt and eliminate blood cancers such as non-Hodgkin's lymphoma and leukemia. In autoimmune disease, we are conducting early-phase clinical trials to determine whether the same CAR-T platform can reset a misfiring immune system in conditions like lupus and rheumatoid arthritis — treating the root cause rather than just managing symptoms. And in organ transplantation, our patented CAR-T approach aims to train the immune system to accept a donor organ without lifelong immunosuppressive drugs, potentially freeing transplant recipients from the burden of daily medication and its serious side effects. Across all programs, our interdisciplinary team combines biology, chemistry, physics, and advanced genomics to push the boundaries of what cell therapy can achieve.
We have state-of-the-art facilities for conducting research including labs, equipment, and research materials.
We provide end-to-end support tailored to the needs of researchers, clinicians, and industry partners. Through our Cell Therapy Division, clients can access custom CAR-T cell engineering, CRISPR-based gene editing services, and consultation on cell therapy clinical trial design. Our Diagnostics & Testing Division offers a broad suite of analytical services: genetic testing and molecular analysis for clinical and research applications, DNA-based food authentication to verify product origins and labeling accuracy (such as confirming honey provenance or validating poultry sourcing), and comprehensive environmental diagnostics covering water purity, soil composition, and air quality monitoring. We also provide access to our state-of-the-art laboratory facilities, specialized equipment, and research-grade materials for qualifying academic and commercial partners. Whether you need a single assay or an ongoing research collaboration, our team works with you to design a service package that fits your goals.
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.